Posts by:

HITLAB Admin

Protected: Overcoming Challenges in Aortic Surgery: Early Insights into Elika’s Potential

Protected: Overcoming Challenges in Aortic Surgery: Early Insights into Elika’s Potential

Aortic surgeries remain high-risk, in part due to complex techniques like deep hypothermic circulatory arrest (DHCA), which increase the likelihood of complications such as stroke, kidney injury, and prolonged recovery. Elika, developed by Octin Health, is a novel cardiopulmonary bypass cannula that enables continuous perfusion during aortic arch surgery, eliminating the need for DHCA.
HITLAB Partner Octin Health Selected to join 2025 MedTech Innovation Cohort

HITLAB Partner Octin Health Selected to join 2025 MedTech Innovation Cohort

Octin Health, an emerging medical device startup, has partnered with HITLAB to accelerate the development and clinical validation of its flagship device, Elika. Designed to simplify aortic arch surgeries, Elika aims to make these complex procedures safer, more accessible, and cost-effective. Through this collaboration, Octin will leverage HITLAB’s expertise to validate Elika’s economic model, generate clinical evidence, and refine usability, ensuring the device is safe, affordable, and user-friendly.